AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Emicizumab in Nigeria

3 products registered with NAFDAC 3 active

Brand / ProductReg. No.HolderStatusExpires
Hemlibra 150 mg
Solution for injection
A6-100134active
Hemlibra 30 mg
Solution for injection
A6-100132active
Hemlibra 60 mg
Solution for injection
A6-100133active

EmicizumabNAFDAC Registration Details

NAFDAC (Nigeria) has 3 registered products containing Emicizumab, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Emicizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.